. . .

We’re excited to announce that in recognition of our continued dedication to exceptional quality pharma services, we have just passed our latest GMP inspection by the Czech State Institute for Drug Control, SUKL.

Inspecting QUINTA-ANALYTICA’s facilities in our HQ in Prague and also at our newest lab in the southern Czech city of Brno, the pass in both locations this week once again confirms our position as a fully certified service provider to the global pharmaceutical industry. Something we’ve been doing for over twenty years.

Providing services that span the whole pharmaceutical spectrum and combining them with unrivaled expertise across analytical services, clinical studies, R&D and more, passing both inspections eulogizes another year of growth and success for Quinta and, most importantly, our partners and clients!

Additional News

  • 20 November 2025

    Webinar: Streamlined Evidence Strategies for Biosimilars: Analytics, PK and Immunogenicity in focus

    On behalf of Conscio Group, we are pleased to invite you to the upcoming free educational webinar from biosimilar series.

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).